Pacemakers

Overview

Implantable pacemakers are small devices utilized to restore normal cardiac function in cases of low heart rate (bradycardia). They consist of the main generator unit and transvenous leads (ranging from 1 to 3, depending on the system type). The generator is implanted via a 3–4 cm incision within a subcutaneous pocket, while the leads are introduced through local veins and guided via the venous system into their precise anatomical positions inside the heart.

The device generates low-energy electrical impulses that travel through the leads to stimulate the myocardium and initiate cardiac contractions.

How Do They Work?

As previously noted, pacemakers comprise a pulse generator and specific pacing leads. These leads are positioned in the right atrium, the right ventricle, and within the venous network of the coronary sinus when a biventricular pacing system is required. Through these leads, the pacemaker can deliver electrical impulses to induce cardiac contractions—a process known as pacing. Concurrently, it can monitor the heart’s intrinsic electrical activity, a function termed sensing. If intrinsic cardiac activity is detected, the pacemaker’s output is inhibited, allowing the heart to function naturally. Conversely, if no intrinsic electrical impulse is sensed within a designated timeframe, the pacemaker emits electrical signals to support continuous cardiac function.

Clinical Indications for Pacemaker Implantation

In cases of sick sinus syndrome (SSS)—characterized by impaired impulse generation from the sinoatrial (SA) node in the right atrium—atrial pacing alone is typically required, given that atrioventricular (AV) conduction is usually preserved. In this scenario, the device paces only the atria, bypassing the ventricles. All modern pacemakers incorporate algorithms designed to minimize ventricular pacing, as preserving natural AV conduction and physiological ventricular contraction is clinically preferable over artificial ventricular pacing.

Conversely, if an atrioventricular block is present, atrial impulse generation is generally intact, but the conduction of these signals to the ventricles is impaired. In this case, the pacemaker senses the intrinsic atrial rhythm and tracks each impulse down to the ventricles to ensure regular ventricular contractions. Naturally, a patient may present with a combination of both disorders, necessitating a dual-chamber pacing approach that addresses both the atria and the ventricles.

Types of Pacemakers

Pacemakers are categorized into distinct types based on the underlying cardiac pathology:

  • DDDR Pacemakers (Dual-Chamber Pacemakers): This is the most frequently implanted type. It utilizes two leads: one positioned in the right atrium and the other in the right ventricle. Each lead is capable of both sensing and pacing its respective cardiac chamber. The pacemaker’s electronic circuitry processes these incoming cardiac signals alongside programmed operational parameters to ensure synchronized atrial and ventricular contraction, maintaining an uninterrupted and continuous cardiac rhythm. DDDR pacemakers are indicated for both sick sinus syndrome and atrioventricular block.
  • VVIR Pacemakers (Single-Chamber Ventricular Pacemakers): These systems utilize a single lead positioned in the right ventricle. They are indicated for patients with chronic atrial fibrillation who cannot be restored to a normal sinus rhythm. In these cases, the atria do not effectively contract due to fibrillation, rendering atrial sensing and pacing redundant.
  • VDDR Pacemakers: These devices feature a single specialized lead with dual-chamber functionality. Via this single lead, the pacemaker can sense and pace the ventricle, but can only sense—and not pace—the atrium. This type is used in patients with AV block who do not require atrial pacing support. However, atrial sensing via these leads can become unstable over time, potentially leading to later complications. Consequently, VDDR systems are becoming obsolete and are generally reserved for cases with objective anatomical barriers to introducing a second lead through the venous system, or due to operator inexperience.

Pacing Leads

Target Patient Populations

Patients indicated for pacemaker implantation can be broadly categorized as follows:

  • Patients with Sick Sinus Syndrome: In this condition, the heart’s natural pacemaker, the sinoatrial node, fails, resulting in severe bradycardia. Patients experience impaired impulse generation at the SA node level. This can manifest as severe resting bradycardia (< 40 beats per minute) or prolonged sinus pauses lasting several seconds, causing significant symptoms. Additionally, patients may experience chronotropic incompetence, failing to appropriately increase their heart rate during physical exertion. Generally, a mean 24-hour heart rate below 50 beats per minute—in the absence of negative chronotropic medications (such as beta-blockers, verapamil, diltiazem, or digoxin)—indicates sinus node dysfunction. If symptomatic, pacemaker implantation is warranted. Sick sinus syndrome typically develops with advancing age and is prevalent in elderly populations. Sinus bradycardia in athletes is an entirely different physiological phenomenon and should not be confused with sick sinus syndrome.
  • Patients with Atrioventricular Block: This involves impaired conduction of electrical impulses from the atria to the ventricles. Atrioventricular block is classified into first, second, and third-degree blocks. Implantation is indicated for patients with symptomatic second-degree AV block (and in specific asymptomatic cases), as well as those with third-degree or complete AV block. Occasionally, AV block manifests acutely, completely halting impulse transmission to the ventricles. This causes transient ventricular asystole and subsequent syncope, rendering pacemaker implantation an ultra-urgent medical necessity.
  • Patients with Bifascicular or Trifascicular Block and Syncope: These blocks involve conduction delays or interruptions in the specialized intraventricular conduction pathways (right bundle branch, left bundle branch, and its fascicles) that transmit electrical impulses from the AV node to the ventricles. Patients with these conduction abnormalities who present with syncope carry a high risk of sudden, complete infrahisian block during the episode. This leads to transient cardiac standstill, sudden cessation of cerebral blood flow, and abrupt loss of consciousness (Stokes-Adams syncope). Such patients require exhaustive diagnostic evaluation and, in most cases, ultimately undergo pacemaker implantation.
  • Bradycardia-Tachycardia Syndrome: In some instances, patients present with symptomatic tachyarrhythmias, but the administration of necessary antiarrhythmic pharmacotherapy exacerbates the underlying bradycardia, suppressing the natural rhythm and causing secondary symptoms. If these tachyarrhythmias cannot be managed via non-pharmacological interventions (e.g., catheter ablation), a pacemaker may be implanted to provide a safety net, allowing for aggressive up-titration of drug therapy to suppress the tachyarrhythmias. If medical therapy still fails to control atrial tachyarrhythmias—most commonly atrial fibrillation—an AV node ablation may be performed. This induces a therapeutic, complete AV block to prevent rapid ventricular rates driven by atrial tachyarrhythmias, rendering the patient permanently pacemaker-dependent.

Selecting the Optimal Pacemaker Type

The choice of pacemaker model and pacing leads must be personalized by a cardiac electrophysiologist at a specialized center, based on the specific pathology and individual patient characteristics.

The following clinical guidelines should be considered:

  • VVIR Selection Limitations: Choosing the simplest pacemaker (VVIR) should strictly be restricted to patients with chronic atrial fibrillation where there is no clinical probability of restoring sinus rhythm spontaneously or pharmacologically. In practice, VVIR pacemakers are sometimes erroneously implanted in patients with paroxysmal atrial fibrillation and sick sinus syndrome. This error typically stems from limited operator experience in positioning a right atrial lead, or as a cost-cutting measure. This practice, occasionally observed in certain public healthcare institutions, remains a clinical error. If a sinus rhythm persists, VVIR pacing reverses normal physiological cardiac sequence (ventricular contraction precedes atrial contraction). This phenomenon can induce "pacemaker syndrome," causing severe dyspnea and potentially progressing to severe, overt heart failure.
  • VDDR vs. DDDR in AV Block: Implantation of a VDDR pacemaker in patients with complete AV block can be an acceptable alternative, as utilizing a single dual-function lead simplifies the surgical procedure. This approach assumes the atria do not, and will not, require pacing support. However, clinical experience has shown that the dual-chamber functionality of single-pass leads often degrades over time, creating late complications. Therefore, high-volume centers with sufficient expertise have standardized the implantation of dual-lead DDDR systems for patients with complete AV block.
  • MRI-Conditional Systems: The utilization of MRI-conditional pacing systems is of paramount importance, particularly for patients with co-morbidities requiring regular longitudinal MRI monitoring. Given that any patient may potentially require an MRI scan in the future, it is clinically recommended that MRI-conditional systems be implanted universally.
  • Biventricular Pacing: In patients presenting with heart failure, a reduced left ventricular ejection fraction (HFrEF), and an indication for ventricular pacing, a biventricular pacing system (cardiac resynchronization therapy, CRT-P or CRT-D) must be implanted.

Surgical Procedure

The implantation procedure is performed in the cardiac catheterization or electrophysiology laboratory under local anesthesia. No extensive preoperative preparation is required. If the patient is on oral anticoagulants, a perioperative management plan must be coordinated with the clinical team. In cases of atrial fibrillation with a high thromboembolic risk profile, anticoagulation may be continued without interruption. Intravenous antibiotic prophylaxis is administered immediately prior to the incision to mitigate infection risks.

The procedure typically lasts between 30 and 60 minutes. A 3–4 cm incision is made in the infraclavicular region (utilizing either the left or right side). Access is obtained via the subclavian or cephalic vein, through which 1 or 2 leads are advanced and positioned into the right ventricle and/or right atrium (for biventricular pacing, a third lead is introduced into the venous network of the coronary sinus). Once optimal electrical parameters (sensing, thresholds, and impedance) are verified via intraoperative testing, the leads are secured to the underlying pectoral fascia using non-absorbable sutures. The leads are then connected to the pulse generator, which is placed inside a meticulously prepared subcutaneous pocket. Finally, the incision is closed in layers, and the patient is transferred to the ward.

Mobilization occurs either on the same day or the following morning, with the procedure typically requiring a single overnight hospital stay. Mild localized postoperative pain may be managed with standard over-the-counter analgesics.

Longitudinal Patient Follow-Up

Pacemaker function is evaluated non-invasively using dedicated external programmers available at implanting institutions. Each device manufacturer utilizes a proprietary programming system. These programmers enable clinicians to assess electronic telemetry, adjust pacing parameters, and modify settings. The initial interrogation is typically scheduled one month post-implantation, followed by routine follow-up intervals every 6 to 12 months.

During each device interrogation, clinicians evaluate lead integrity, remaining battery capacity (longevity), and retrieve stored arrhythmia logs from the device memory. This provides critical data regarding the patient’s burden of arrhythmias, guiding subsequent adjustments to medical therapy.

Post-Implantation Lifestyle Modifications

Transient localized discomfort at the incision site is common immediately post-op and responds well to simple analgesics. Over the following days, this sensation subsides, and most patients adapt completely, noting no awareness of the foreign body.

During the initial 2-month post-operative window—and critically within the first 15 days—patients are instructed to avoid extreme movements of the ipsilateral upper extremity to prevent lead dislodgement, as the leads are anchored to the underlying pectoral musculature.

Modern pacing systems demonstrate excellent electromagnetic compatibility and are unaffected by standard household electrical or electronic appliances. Similarly, external security screening systems in banks, commercial retail environments, and airports do not interfere with device function. Standard technical maintenance work using common electrical tools is generally safe.

Regarding medical diagnostics, patients with a pacemaker are strictly contraindicated from undergoing Magnetic Resonance Imaging (MRI) unless they have a verified, fully MRI-conditional pacing system.

Overall, individuals with pacemakers maintain an excellent quality of life. In many instances, the therapeutic support and safety net provided by the pacemaker allow patients to engage in a wider, more active range of daily activities.

Complications and Adverse Events

Pacemaker implantation is a highly safe procedure, even when performed in elderly populations. Patients advanced in age (> 80–85 years) constitute the vast majority of the clinical demographic requiring pacing therapy. Complication rates are inversely proportional to operator and institutional procedural volume. However, the following complications may occasionally arise:

  • Pocket Hematoma: This refers to localized blood accumulation within the device pocket, occurring most frequently in patients receiving antithrombotic or anticoagulant therapy. It represents the most common complication (5–10%). Most hematomas reabsorb spontaneously; surgical re-exploration is rarely required. Early diagnosis is essential, and management typically involves applying a localized pressure dressing to the pacemaker site for several days.
  • Lead Dislodgement: If a lead shifts from its optimal anatomical position, its sensing and pacing capabilities degrade, compromising overall system function. Dislodgement is diagnosed via surface electrocardiography (ECG) or through device interrogation. While the risk of dislodgement is always present, it is minimized by operator experience. Most lead dislodgements require surgical revision and repositioning via re-opening of the pocket.
  • Device Infection: Infraclavicular pocket infections typically present superficially with localized erythema, warmth, and purulent drainage. The incidence is low (< 0.5%) and occurs more frequently during generator replacements or revisions than during de novo implantations.
  • Subclavian Vein Thrombosis or Occlusion: This involves partial or complete thrombosis of the venous pathway housing the pacing leads, which can impede regional venous return. It manifests as ipsilateral upper extremity edema, typically developing days after the procedure. This complication occurs in < 0.5% of cases and almost universally resolves with conservative medical management within a few weeks.
  • Pneumothorax: A pneumothorax occurs when air enters the pleural space from the lung, causing potential lung collapse, mediastinal shift, and acute respiratory distress in severe cases. This typically results from inadvertent pulmonary puncture during access attempts into the adjacent subclavian vein. Mild pneumothoraces (small air volume) often resolve spontaneously over several days without active intervention. Severe or tension pneumothoraces require immediate insertion of a small chest tube (Bülau catheter) to evacuate air from the pleural cavity, typically extending hospital stay by 4–5 days. In high-volume centers utilizing rigorous safety measures, this complication is largely avoided.
  • Cardiac Tamponade: This intraoperative complication occurs if a pacing lead—particularly active-fixation leads—perforates the myocardium, allowing blood to escape into the pericardial sac. This rare event (1–3 per 1,000 cases) requires immediate management via emergency pericardiocentesis to drain the pericardial space. Typically, the myocardial micro-perforation seals spontaneously, requiring only a slight extension of hospital stay without permanent sequelae. Surgical sternotomy or thoracotomy is exceptionally rare.

Generator Replacement

When the pacemaker battery reaches its End of Service (EOS) criteria—typically 8 to 12 years following initial implantation—the generator must be replaced. The battery is integrated into the pulse generator unit. The procedure involves reopening the cutaneous incision, disconnecting the generator from the indwelling leads, removing the old unit, and connecting a new pulse generator to the existing leads.

The indwelling leads remain in place unless lead malfunction or insulation failure is detected, in which case new leads are extracted or abandoned as new ones are advanced. Generator replacement is technically simpler and faster than de novo implantation, often allowing for same-day patient discharge.

2026-11-18T22:44:49+00:00